ATE544749T1 - Verfahren zur synthetisierung pharmazeutischer salze aus einem faktor-xa-hemmer - Google Patents
Verfahren zur synthetisierung pharmazeutischer salze aus einem faktor-xa-hemmerInfo
- Publication number
- ATE544749T1 ATE544749T1 AT07863800T AT07863800T ATE544749T1 AT E544749 T1 ATE544749 T1 AT E544749T1 AT 07863800 T AT07863800 T AT 07863800T AT 07863800 T AT07863800 T AT 07863800T AT E544749 T1 ATE544749 T1 AT E544749T1
- Authority
- AT
- Austria
- Prior art keywords
- inhibitor
- factor
- pharmaceutical salts
- synthesizing pharmaceutical
- synthesizing
- Prior art date
Links
- 229940123583 Factor Xa inhibitor Drugs 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
- 230000002194 synthesizing effect Effects 0.000 title 1
- 108010074860 Factor Xa Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 150000002688 maleic acid derivatives Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/90—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having more than three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86414506P | 2006-11-02 | 2006-11-02 | |
| PCT/US2007/083394 WO2008057972A1 (en) | 2006-11-02 | 2007-11-01 | Methods of synthesizing pharmaceutical salts of a factor xa inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE544749T1 true ATE544749T1 (de) | 2012-02-15 |
Family
ID=39167635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07863800T ATE544749T1 (de) | 2006-11-02 | 2007-11-01 | Verfahren zur synthetisierung pharmazeutischer salze aus einem faktor-xa-hemmer |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US8524907B2 (de) |
| EP (2) | EP2077995B1 (de) |
| CN (1) | CN101595092B (de) |
| AT (1) | ATE544749T1 (de) |
| AU (1) | AU2007317376B2 (de) |
| CA (1) | CA2667488C (de) |
| ES (2) | ES2550057T3 (de) |
| PT (2) | PT2404906E (de) |
| WO (1) | WO2008057972A1 (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7696352B2 (en) * | 2004-06-18 | 2010-04-13 | Millennium Pharmaceuticals, Inc. | Factor Xa inhibitors |
| CN101304971B (zh) | 2005-11-08 | 2011-09-07 | 米伦纽姆医药公司 | Xa因子抑制剂n-(5-氯-2-吡啶基)-2-[[4-[(二甲氨基)亚氨基甲基]苯甲酰基]氨基]-5-甲氧基-苯甲酰胺的医药盐和多晶型 |
| EP2016072B1 (de) | 2006-05-05 | 2014-07-16 | Millennium Pharmaceuticals, Inc. | Faktor-xa-hemmer |
| EP2077995B1 (de) * | 2006-11-02 | 2012-02-08 | Millennium Pharmaceuticals, Inc. | Verfahren zur synthetisierung pharmazeutischer salze aus einem faktor-xa-hemmer |
| EP2155195B1 (de) | 2007-04-13 | 2014-07-16 | Millennium Pharmaceuticals, Inc. | Gerinnungshemmende Kombinationstherapie mit einer Verbindung, die als Faktor-Xa-Hemmer wirkt |
| JP5766204B2 (ja) * | 2009-12-17 | 2015-08-19 | ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. | 第Xa因子阻害剤の合成方法 |
| US8742120B2 (en) * | 2009-12-17 | 2014-06-03 | Millennium Pharmaceuticals, Inc. | Methods of preparing factor xa inhibitors and salts thereof |
| EP2513094B1 (de) | 2009-12-17 | 2015-12-16 | Millennium Pharmaceuticals, Inc. | Salze und kristalline formen eines faktor-xa-inhibitors |
| TW201221128A (en) | 2010-09-01 | 2012-06-01 | Portola Pharm Inc | Crystalline forms of a factor Xa inhibitor |
| US20140346397A1 (en) | 2012-12-27 | 2014-11-27 | Portola Pharmaceuticals, Inc. | Compounds and methods for purification of serine proteases |
| US9200268B2 (en) | 2012-12-27 | 2015-12-01 | Portola Pharmaceuticals, Inc. | Compounds and methods for purification of serine proteases |
| CN104341343B (zh) * | 2013-07-24 | 2018-09-28 | 四川海思科制药有限公司 | 贝曲西班的晶型及其制备方法和用途 |
| CN104693114B (zh) * | 2013-12-10 | 2019-08-16 | 四川海思科制药有限公司 | 一种贝曲西班的改进的制备方法 |
| CN105085387A (zh) * | 2014-05-20 | 2015-11-25 | 四川海思科制药有限公司 | 贝曲西班盐及其制备方法和用途 |
| EP3078378B1 (de) | 2015-04-08 | 2020-06-24 | Vaiomer | Verwendung von faktor-xa-inhibitoren zur regulierung von glykämie |
| WO2017091757A1 (en) | 2015-11-24 | 2017-06-01 | Portola Pharmaceuticals, Inc. | Isotopically enriched betrixaban |
| CN105348187B (zh) * | 2015-12-02 | 2017-12-08 | 安徽省逸欣铭医药科技有限公司 | 一种贝曲西班结构类似物及其制备方法和用途 |
| CN105732490A (zh) * | 2016-03-25 | 2016-07-06 | 重庆医科大学 | 一种贝曲西班的制备方法 |
| EP3293174A1 (de) * | 2016-09-09 | 2018-03-14 | Sandoz Ag | Kristalline formen von betrixaban |
| WO2018229796A2 (en) * | 2017-06-14 | 2018-12-20 | Mylan Laboratories Limited | A process for betrixaban hydrochloride and betrixaban maleate salt |
| CN108570003A (zh) * | 2018-06-01 | 2018-09-25 | 浙江宏元药业股份有限公司 | 一种贝曲西班马来酸盐的一水无定形及其制备方法 |
Family Cites Families (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2095619A (en) * | 1937-10-12 | Aryl oxides | ||
| CH520657A (de) | 1961-09-11 | 1972-03-31 | Wander Ag Dr A | Verfahren zur Herstellung mehrbasischer Verbindungen |
| GB1047245A (de) | 1963-02-15 | |||
| GB2095239B (en) * | 1981-02-27 | 1985-03-06 | Torii & Co Ltd | Novel amidine compounds |
| US4500714A (en) | 1981-10-15 | 1985-02-19 | Chugai Seiyaku Kabushiki Kaisha | 3-Substituted-ureido-N-pyridyl benzamides |
| US4588587A (en) * | 1983-03-01 | 1986-05-13 | Pennsylvania Hospital | Method of treatment to inhibit metastasis |
| JPS59181257A (ja) | 1983-03-31 | 1984-10-15 | Chugai Pharmaceut Co Ltd | ウレイドベンズアミド誘導体 |
| JP2668231B2 (ja) * | 1987-12-29 | 1997-10-27 | 大日精化工業株式会社 | 電子写真感光体 |
| AU606808B2 (en) | 1988-06-29 | 1991-02-14 | Otsuka Pharmaceutical Factory, Inc. | Arylcarboxamide substituted by alkylphosphonates, process for preparing the same and a pharmaceutical composition containing the same |
| GB9816837D0 (en) | 1998-08-04 | 1998-09-30 | Zeneca Ltd | Amide derivatives |
| ZA928276B (en) | 1991-10-31 | 1993-05-06 | Daiichi Seiyaku Co | Aromatic amidine derivates and salts thereof. |
| US5612360A (en) * | 1992-06-03 | 1997-03-18 | Eli Lilly And Company | Angiotensin II antagonists |
| JPH08504769A (ja) | 1992-12-15 | 1996-05-21 | コルバス・インターナショナル、インコーポレイテッド | 因子Xaの新規インヒビター |
| GB9226238D0 (en) | 1992-12-16 | 1993-02-10 | Scherer Ltd R P | Encapsulation apparatus and process |
| US5610335A (en) | 1993-05-26 | 1997-03-11 | Cornell Research Foundation | Microelectromechanical lateral accelerometer |
| NZ296210A (en) | 1994-12-02 | 1998-05-27 | Yamanouchi Pharma Co Ltd | Amidinonaphthyl derivatives to inhibit activated blood coagulation factor x |
| EP0742208A1 (de) * | 1995-05-05 | 1996-11-13 | Grelan Pharmaceutical Co., Ltd. | 2-Ureido-benzamid-Derivate |
| US5849759A (en) | 1995-12-08 | 1998-12-15 | Berlex Laboratories, Inc. | Naphthyl-substituted benzimidazole derivatives as anti-coagulants |
| US5994375A (en) | 1996-02-12 | 1999-11-30 | Berlex Laboratories, Inc. | Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants |
| WO1998006694A1 (en) | 1996-08-16 | 1998-02-19 | Du Pont Pharmaceuticals Company | Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof |
| EP0934068A1 (de) | 1996-09-09 | 1999-08-11 | Smithkline Beecham Corporation | Verbindungen und verfahren |
| CA2276034A1 (en) | 1996-12-23 | 1998-07-02 | Mimi Lifen Quan | Oxygen or sulfur containing 5-membered heteroaromatics as factor xa inhibitors |
| CA2275796A1 (en) | 1996-12-23 | 1998-07-02 | Donald Joseph Phillip Pinto | Nitrogen containing heteroaromatics as factor xa inhibitors |
| WO1998057934A1 (en) | 1997-06-19 | 1998-12-23 | The Du Pont Merck Pharmaceutical Company | (AMIDINO)6-MEMBERED AROMATICS AS FACTOR Xa INHIBITORS |
| JP2002506462A (ja) | 1997-06-26 | 2002-02-26 | イーライ・リリー・アンド・カンパニー | 抗血栓物質 |
| IL133625A0 (en) | 1997-06-26 | 2001-04-30 | Lilly Co Eli | Antithrombotic agents |
| CA2294240A1 (en) | 1997-06-26 | 1999-01-07 | Trelia Joyce Craft | Antithrombotic agents |
| EP1014962A4 (de) | 1997-06-26 | 2007-06-27 | Lilly Co Eli | Antitrombotische mitteln |
| US5908841A (en) | 1997-08-11 | 1999-06-01 | Boehringer Ingelheim Pharmaceuticals, Inc. | 5,11-dihydro-6H-dipyrido 3,2-b:2',3'-e!azepine-6-ones and their use in the prevention of treatment of HIV infection |
| EP1020434A4 (de) | 1997-08-27 | 2000-11-15 | Kissei Pharmaceutical | 3-amidinoanilin-derivate, inhibitoren des aktivierten blutgerinnungsfaktors x und zwischenpodukte zur herstellung beider |
| US6140351A (en) * | 1997-12-19 | 2000-10-31 | Berlex Laboratories, Inc. | Ortho-anthranilamide derivatives as anti-coagulants |
| NZ503809A (en) | 1997-12-19 | 2002-04-26 | Schering Ag | Ortho-anthranilamide derivatives as anti-coagulants |
| EP0937711A1 (de) | 1998-02-18 | 1999-08-25 | Roche Diagnostics GmbH | Neue Thiobenzamide, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel |
| JPH11302177A (ja) | 1998-04-27 | 1999-11-02 | Otsuka Pharmaceut Factory Inc | 腎炎治療剤 |
| ATE267824T1 (de) | 1998-12-09 | 2004-06-15 | Wyeth Corp | Alpha-methylbenzyl-enthaltende thioharnstoffe als inhibitoren von herpes-viren mit einer phenylenediamingruppe |
| CN1333750A (zh) | 1998-12-09 | 2002-01-30 | 美国家庭用品有限公司 | 含乙酰胺和取代的乙酰胺的疱疹病毒硫脲抑制剂 |
| ID30158A (id) | 1998-12-09 | 2001-11-08 | American Home Prod | Thiourea yang mengandung heterosiklik karboksamida, pencegah-pencegah virus-virus herpes yang mengandung gugus fenilenadiamina |
| WO2000034269A1 (en) | 1998-12-09 | 2000-06-15 | American Home Products Corporation | Thiourea inhibitors of herpes viruses |
| EP1137632B1 (de) | 1998-12-09 | 2004-07-28 | Wyeth | Thioharnstoff-inhibitoren von herpes-virus |
| CN1367785A (zh) | 1998-12-09 | 2002-09-04 | 美国家庭用品有限公司 | 含取代的苯二胺基团的含杂环羧酰胺的疱疹病毒硫脲抑制剂 |
| BR9915993A (pt) | 1998-12-09 | 2001-09-04 | American Home Prod | Composto, composição farmacêutica, processo para inibir a replicação de um vìrus herpes, e, processo para tratar um paciente sofrendo de uma infecção de vìrus herpes |
| CA2361149A1 (en) | 1998-12-23 | 2000-07-06 | Eli Lilly And Company | Aromatic amides |
| CZ2002961A3 (cs) | 1999-09-17 | 2002-08-14 | Millennium Pharmaceuticals, Inc. | Benzamidy a příbuzné sloučeniny pro inhibici faktoru Xa |
| US6720317B1 (en) * | 1999-09-17 | 2004-04-13 | Millennium Pharmaceuticals, Inc. | Inhibitors of factor Xa |
| US6632815B2 (en) * | 1999-09-17 | 2003-10-14 | Millennium Pharmaceuticals, Inc. | Inhibitors of factor Xa |
| US6844367B1 (en) * | 1999-09-17 | 2005-01-18 | Millennium Pharmaceuticals, Inc. | Benzamides and related inhibitors of factor Xa |
| WO2001064642A2 (en) | 2000-02-29 | 2001-09-07 | Cor Therapeutics, Inc. | Benzamides and related inhibitors of factor xa |
| AU776053B2 (en) * | 2000-03-31 | 2004-08-26 | Astellas Pharma Inc. | Diazepan derivatives or salts thereof |
| SI1309555T1 (sl) * | 2000-12-29 | 2005-12-31 | Pfizer Ltd | Postopek izdelave amlodipin-maleata |
| US7312235B2 (en) * | 2001-03-30 | 2007-12-25 | Millennium Pharmaceuticals, Inc. | Benzamide inhibitors of factor Xa |
| US6627646B2 (en) * | 2001-07-17 | 2003-09-30 | Sepracor Inc. | Norastemizole polymorphs |
| US7022695B2 (en) * | 2003-10-09 | 2006-04-04 | Millennium Pharmaceuticals, Inc. | Thioether-substituted benzamides as inhibitors of Factor Xa |
| KR101195801B1 (ko) * | 2004-06-18 | 2012-11-05 | 밀레니엄 파머슈티컬스 인코퍼레이티드 | Xa 인자 억제제 |
| US7696352B2 (en) * | 2004-06-18 | 2010-04-13 | Millennium Pharmaceuticals, Inc. | Factor Xa inhibitors |
| CN101304971B (zh) * | 2005-11-08 | 2011-09-07 | 米伦纽姆医药公司 | Xa因子抑制剂n-(5-氯-2-吡啶基)-2-[[4-[(二甲氨基)亚氨基甲基]苯甲酰基]氨基]-5-甲氧基-苯甲酰胺的医药盐和多晶型 |
| WO2007112367A2 (en) * | 2006-03-27 | 2007-10-04 | Portola Pharmaceuticals, Inc. | Potassium channel modulators and platelet procoagulant activity |
| EP2016072B1 (de) * | 2006-05-05 | 2014-07-16 | Millennium Pharmaceuticals, Inc. | Faktor-xa-hemmer |
| EP2077995B1 (de) * | 2006-11-02 | 2012-02-08 | Millennium Pharmaceuticals, Inc. | Verfahren zur synthetisierung pharmazeutischer salze aus einem faktor-xa-hemmer |
| PT2101760E (pt) * | 2006-12-08 | 2013-05-07 | Millennium Pharm Inc | Formulações de dose unitária e métodos de tratamento da trombose com um inibidor oral do fator xa |
| CA2674924A1 (en) * | 2007-01-05 | 2008-07-17 | Millennium Pharmaceuticals, Inc. | Factor xa inhibitors |
| EP2155195B1 (de) * | 2007-04-13 | 2014-07-16 | Millennium Pharmaceuticals, Inc. | Gerinnungshemmende Kombinationstherapie mit einer Verbindung, die als Faktor-Xa-Hemmer wirkt |
| KR101509829B1 (ko) * | 2007-05-02 | 2015-04-06 | 포톨라 파마슈티컬스, 인코포레이티드 | 혈소판 adp 수용체 억제제로 작용하는 화합물을 이용한 병용요법 |
| JP5766204B2 (ja) * | 2009-12-17 | 2015-08-19 | ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. | 第Xa因子阻害剤の合成方法 |
-
2007
- 2007-11-01 EP EP07863800A patent/EP2077995B1/de active Active
- 2007-11-01 CA CA2667488A patent/CA2667488C/en not_active Expired - Fee Related
- 2007-11-01 CN CN2007800399575A patent/CN101595092B/zh active Active
- 2007-11-01 PT PT111838538T patent/PT2404906E/pt unknown
- 2007-11-01 ES ES11183853.8T patent/ES2550057T3/es active Active
- 2007-11-01 PT PT07863800T patent/PT2077995E/pt unknown
- 2007-11-01 US US12/446,954 patent/US8524907B2/en active Active
- 2007-11-01 ES ES07863800T patent/ES2382055T3/es active Active
- 2007-11-01 AU AU2007317376A patent/AU2007317376B2/en not_active Ceased
- 2007-11-01 EP EP11183853.8A patent/EP2404906B1/de active Active
- 2007-11-01 AT AT07863800T patent/ATE544749T1/de active
- 2007-11-01 WO PCT/US2007/083394 patent/WO2008057972A1/en not_active Ceased
-
2013
- 2013-08-08 US US13/962,819 patent/US9221758B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2077995B1 (de) | 2012-02-08 |
| US20140046071A1 (en) | 2014-02-13 |
| CN101595092B (zh) | 2012-02-01 |
| US8524907B2 (en) | 2013-09-03 |
| AU2007317376B2 (en) | 2013-01-17 |
| EP2077995A1 (de) | 2009-07-15 |
| ES2550057T3 (es) | 2015-11-04 |
| US20100197929A1 (en) | 2010-08-05 |
| ES2382055T3 (es) | 2012-06-04 |
| CA2667488A1 (en) | 2008-05-15 |
| CN101595092A (zh) | 2009-12-02 |
| AU2007317376A1 (en) | 2008-05-15 |
| HK1165426A1 (en) | 2012-10-05 |
| HK1133258A1 (en) | 2010-03-19 |
| US9221758B2 (en) | 2015-12-29 |
| EP2404906B1 (de) | 2015-07-15 |
| EP2404906A1 (de) | 2012-01-11 |
| CA2667488C (en) | 2015-07-07 |
| WO2008057972A1 (en) | 2008-05-15 |
| PT2077995E (pt) | 2012-05-10 |
| PT2404906E (pt) | 2015-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2404906E (pt) | Métodos de sintetizar sais farmacêuticos de um inibidor de fator xa | |
| EA200970569A1 (ru) | Применимые в качестве гербицидных соединений пиридопиразиновые производные | |
| ATE540931T1 (de) | Verfahren zur synthese organischer verbindungen | |
| ATE553083T1 (de) | Verfahren zur herstellung eines 2- pyridylethylcarbonsäureamidderivats | |
| DK2091948T3 (da) | Nye inhibitorer af glutaminylcyclase | |
| EA201100666A1 (ru) | Тиоамидные соединения, способ их получения и способ их применения | |
| CY1113716T1 (el) | Νεα μεθοδος συνθεσης της αγομελατινης | |
| CY1112829T1 (el) | Νεα μεθοδος συνθεσης για την αγομελατινη | |
| ATE539054T1 (de) | Verfahren zur herstellung von dihydropyrrolderivaten als zwischenprodukte | |
| CY1112520T1 (el) | Βενζυλαμινες, μια διαδικασια για την παραγωγη τους και η χρηση τους ως αντι-φλεγμονωδεις παραγοντες | |
| EA201300250A1 (ru) | Оксадиазольные ингибиторы продуцирования лейкотриена | |
| ATE490956T1 (de) | Verfahren zur herstellung eines 2- ethylaminopyridinderivats | |
| GEP20115166B (en) | 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS | |
| ATE497769T1 (de) | Verfahren zur herstellung von ibandronat | |
| EA201100696A1 (ru) | 1-(арилсульфонил)-4-(пиперазин-1-ил)-1h-бензимидазолы в качестве лигандов 5-гидрокситриптамина-6 | |
| EA200701470A1 (ru) | Способы получения производных 4-(фенокси-5-метилпиримидин-4-илокси)пиперидин-1-карбоновой кислоты и родственных соединений | |
| ATE465152T1 (de) | Verfahren zum herstellen von alkylaniliden aus halogenbenzolderivaten | |
| EA200800502A1 (ru) | Соединения 3-аминокарбазола, фармацевтическая композиция, содержащая указанные соединения, и способ их получения | |
| ZA200800091B (en) | Method for producing salts of hydrocyanic acid | |
| CY1111573T1 (el) | Νεα μεθοδος συνθεσης της αγομελατινης | |
| ATE532516T1 (de) | Verfahren zur synthese von glyt-1-hemmern | |
| ATE398118T1 (de) | Verfahren zur synthese einer benzimidazolverbindung | |
| EA201001252A1 (ru) | Способ получения производных 3,6-дигидро-1,3,5-триазина | |
| EP2061492A4 (de) | Verfahren zur linderung von schmerzen durch modifikation von nmda-rezeptoren durch hemmung von src | |
| DE602005020135D1 (de) | Verfahren zur veränderung der alkaloidzusammensetzung von mohnpflanzen |